IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management III, LLC

Portfolio Profile

CIK: 0001738053 | New York, NY

$160.3M
AUM
18
Positions
99.97%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Axsome Therapeutics Inc(AXSM)1,547,994$160.0M99.79%
2Constellation Pharmaceuticals(CNST)2,516,242$118.5K0.07%
3Milestone Pharmaceuticals Inc(MIST)2,066,529$33.1K0.02%
4Relmada Therapeutics Inc(RLMD)767,938$30.0K0.02%
589Bio Inc(ETNBGBP)958,765$25.2K0.02%
610X Genomics Inc.(TXG)300,000$22.9K0.01%
7Forty Seven Inc(FTSVEUR)516,381$20.3K0.01%
8Intra-Cellular Therapies Inc(ITCIEUR)575,000$19.7K0.01%
9Iveric Bio Inc(OPHTEUR)1,699,797$14.6K0.01%
10Kalvista Pharmaceuticals(KALV)619,905$11.0K0.01%

Sector Allocation

Latest filing, equity positions only

Healthcare99.85% · $160.1M
Unclassified0.15% · $246.1K

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare99.88%99.85%-0.03%
Unclassified0.12%0.15%+0.03%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$23.5M | 13 pos.
$24.8M | 15 pos.
$40.2M | 16 pos.
$51.9M | 17 pos.
$40.5M | 17 pos.
$160.3M | 18 pos.
Cap SizePrev %Curr %Change
Mid Cap99.77%99.8%+0.03%
Unclassified0.12%0.15%+0.03%
Small Cap0.02%0.03%+0.01%
Micro Cap0.1%0.02%-0.08%
Q3
18
Q4
18
Q1
19
Q2
19
Q3
19
Q4
19

Recent Activity

Quarter-over-quarter position changes

9
New
8
Closed
2
Increased
5
Decreased
2
Unchanged